128 related articles for article (PubMed ID: 38847538)
41. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
[TBL] [Abstract][Full Text] [Related]
42. Colonization and Infection With Extensively Drug Resistant Gram-Negative Bacteria in Liver Transplant Recipients.
Massa E; Michailidou E; Agapakis D; Papadopoulos S; Tholioti T; Aleuroudis I; Bargiota T; Passakiotou M; Daoudaki M; Antoniadis N; Imvrios G; Iosifidis E; Vagdatli E; Roilides E; Vasilakos D; Fouzas I; Mouloudi E
Transplant Proc; 2019 Mar; 51(2):454-456. PubMed ID: 30879565
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of Genotypic and Phenotypic Methods to Detect Carbapenemase Production in Gram-Negative Bacilli.
McMullen AR; Yarbrough ML; Wallace MA; Shupe A; Burnham CD
Clin Chem; 2017 Mar; 63(3):723-730. PubMed ID: 28073895
[TBL] [Abstract][Full Text] [Related]
44. The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations.
Aslan AT; Akova M
Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203879
[TBL] [Abstract][Full Text] [Related]
45. Ceftazidime-avibactam in the treatment of bacteremia due to carbapenem-resistant gram-negative bacteria in hematological patients: Experience in a single center.
Zhen S; Lin Q; Chen Z; Shen Y; Chen X; Pang A; Yang D; Zhang R; Ma Q; He Y; Wei J; Zhai W; Jiang E; Han M; Wang J; Feng S
J Infect Chemother; 2024 Jul; 30(7):608-615. PubMed ID: 38215820
[TBL] [Abstract][Full Text] [Related]
46. Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections.
Zhen S; Wang H; Feng S
Infection; 2022 Dec; 50(6):1409-1423. PubMed ID: 35781869
[TBL] [Abstract][Full Text] [Related]
47. Bloodstream Infections in Patients with Rectal Colonization by Carbapenem-Resistant Enterobacteriaceae: A Prospective Cohort Study.
Chu W; Hang X; Li X; Ye N; Tang W; Zhang Y; Yang X; Yang M; Wang Y; Liu Z; Zhou Q
Infect Drug Resist; 2022; 15():6051-6063. PubMed ID: 36277248
[TBL] [Abstract][Full Text] [Related]
48. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
[TBL] [Abstract][Full Text] [Related]
49. Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria.
Garg A; Garg J; Kumar S; Bhattacharya A; Agarwal S; Upadhyay GC
Indian J Med Res; 2019 Feb; 149(2):285-289. PubMed ID: 31219096
[TBL] [Abstract][Full Text] [Related]
50. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
[TBL] [Abstract][Full Text] [Related]
51. Intestinal Colonization with Carbapenem-Resistant Enterobacteriaceae in Acute Leukemia Patients: Risk Factors and Molecular Characteristics.
Zhu R; Xu X; Lian S; Cai M; Zhang H; Chen X; Cao Y
Infect Drug Resist; 2022; 15():4275-4283. PubMed ID: 35965853
[TBL] [Abstract][Full Text] [Related]
52. Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Bonuomo V; Busca A; Principe MID; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;
Int J Antimicrob Agents; 2023 Jun; 61(6):106806. PubMed ID: 37030470
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
Wang L; Wang Y; Fan X; Tang W; Hu J
Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
[TBL] [Abstract][Full Text] [Related]
54. Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.
Tian F; Li Y; Wang Y; Yu B; Song J; Ning Q; Jian C; Ni M
Ann Clin Microbiol Antimicrob; 2023 Jan; 22(1):10. PubMed ID: 36710337
[TBL] [Abstract][Full Text] [Related]
55. Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin.
Mabrouk SS; Abdellatif GR; Zaid ASA; Aboshanab KM
BMC Microbiol; 2023 Jul; 23(1):195. PubMed ID: 37481513
[TBL] [Abstract][Full Text] [Related]
56. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
Maina JW; Mutua JM; Musyoki AM
BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
[TBL] [Abstract][Full Text] [Related]
57. Detection and Characterization of Targeted Carbapenem-Resistant Health Care-Associated Threats: Findings from the Antibiotic Resistance Laboratory Network, 2017 to 2019.
Sabour S; Huang JY; Bhatnagar A; Gilbert SE; Karlsson M; Lonsway D; Lutgring JD; Rasheed JK; Halpin AL; Stanton RA; Gumbis S; Elkins CA; Brown AC
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0110521. PubMed ID: 34570648
[TBL] [Abstract][Full Text] [Related]
58. Development and validation of nomograms for predicting the risk probability of carbapenem resistance and 28-day all-cause mortality in gram-negative bacteremia among patients with hematological diseases.
Jian X; Du S; Zhou X; Xu Z; Wang K; Dong X; Hu J; Wang H
Front Cell Infect Microbiol; 2022; 12():969117. PubMed ID: 36683699
[TBL] [Abstract][Full Text] [Related]
59. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of intestinal colonization and nosocomial infection with carbapenem-resistant
Pan F; Chen P; Duan Y; Yu F; Weng W; Zhang H
Front Public Health; 2023; 11():1251609. PubMed ID: 38074706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
